← FDA DRUG APPROVALS

FDA ANDA · ANDA214088

BUTALBITAL AND ACETAMINOPHEN

Sponsor: SENORES PHARMS

APPLICATION
ANDA214088
TYPE
ANDA
ORIGINAL APPROVAL
2022-04-07
LATEST ACTION
2022-04-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

BUTALBITAL AND ACETAMINOPHENPrescription
ACETAMINOPHEN 325MG, BUTALBITAL 50MG · TABLET · ORAL
BUTALBITAL AND ACETAMINOPHENPrescription
ACETAMINOPHEN 300MG, BUTALBITAL 50MG · TABLET · ORAL
BUTALBITAL AND ACETAMINOPHENPrescription
ACETAMINOPHEN 325MG, BUTALBITAL 25MG · TABLET · ORAL

Approval history

2022-04-07UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →